Literature DB >> 10349850

Conserved extracellular cysteine pair in the M3 muscarinic acetylcholine receptor is essential for proper receptor cell surface localization but not for G protein coupling.

F Y Zeng1, A Soldner, T Schöneberg, J Wess.   

Abstract

Most G protein-coupled receptors contain a conserved pair of extracellular cysteine residues that are predicted to form a disulfide bond linking the first and second extracellular loops. Previous studies have shown that this disulfide bond may be critical for ligand binding, receptor activation, and/or proper receptor folding. However, the potential importance of the two conserved cysteine residues for proper receptor cell surface localization has not been investigated systematically. To address this issue, we used the rat M3 muscarinic receptor as a model system. Most studies were carried out with a modified version of this receptor subtype (lacking potential N-glycosylation sites and the central portion of the third intracellular loop) that could be readily detected via western blot analysis. Cys-->Ala mutant receptors were generated, transiently expressed in COS-7 cells, and then examined for their subcellular distribution and functional properties. ELISA and immunofluorescence studies showed that the presence of both conserved cysteine residues (corresponding to C140 and C220 in the rat M3 muscarinic receptor sequence) is required for efficient expression of the M3 muscarinic receptor on the cell surface. On the other hand, these residues were found not to be essential for protein stability (determined via immunoblotting) and receptor-mediated G protein activation (studied in second messenger assays). These results shed new light on the functional role of the two extracellular cysteine residues present in most G protein-coupled receptors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10349850     DOI: 10.1046/j.1471-4159.1999.0722404.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  8 in total

Review 1.  Synthesis, trafficking, and localization of muscarinic acetylcholine receptors.

Authors:  Neil M Nathanson
Journal:  Pharmacol Ther       Date:  2008-05-16       Impact factor: 12.310

Review 2.  Lifting the lid on GPCRs: the role of extracellular loops.

Authors:  M Wheatley; D Wootten; M T Conner; J Simms; R Kendrick; R T Logan; D R Poyner; J Barwell
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

3.  M3 muscarinic receptor interaction with phospholipase C β3 determines its signaling efficiency.

Authors:  Wei Kan; Merel Adjobo-Hermans; Michael Burroughs; Guy Faibis; Sundeep Malik; Gregory G Tall; Alan V Smrcka
Journal:  J Biol Chem       Date:  2014-03-04       Impact factor: 5.157

4.  International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors.

Authors:  Margarita L Dubocovich; Philippe Delagrange; Diana N Krause; David Sugden; Daniel P Cardinali; James Olcese
Journal:  Pharmacol Rev       Date:  2010-07-06       Impact factor: 25.468

5.  Functional heterogeneity of bone morphogenetic protein receptor-II mutants found in patients with primary pulmonary hypertension.

Authors:  Ayako Nishihara; Tetsuro Watabe; Takeshi Imamura; Kohei Miyazono
Journal:  Mol Biol Cell       Date:  2002-09       Impact factor: 4.138

6.  The second extracellular loop of the dopamine D2 receptor lines the binding-site crevice.

Authors:  Lei Shi; Jonathan A Javitch
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-02       Impact factor: 11.205

7.  Investigation of D₂ receptor-agonist interactions using a combination of pharmacophore and receptor homology modeling.

Authors:  Marcus Malo; Lars Brive; Kristina Luthman; Peder Svensson
Journal:  ChemMedChem       Date:  2012-02-07       Impact factor: 3.466

8.  Deciphering and modulating G protein signalling in C. elegans using the DREADD technology.

Authors:  Simone Prömel; Franziska Fiedler; Claudia Binder; Jana Winkler; Torsten Schöneberg; Doreen Thor
Journal:  Sci Rep       Date:  2016-07-27       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.